Company: CCIXW
Filing Date: 2025-12-05
Form Type: S-4/A
Source: 0001193125-25-309933
Chunk: 230

Company: Churchill Capital Corp IX/Cayman
Filing Date: 2025-12-05
Form: S-4/A
Chunk 230
---
 Tomo.

Past performance by MKA and members of our management team or our strategic and operating partners may not be indicative of future performance of an investment in us.

Information regarding performance by, or businesses associated with, MKA and other members of our management team or our strategic and operating partners is presented for informational purposes only. Any past experience or performance, including related to acquisitions, of MKA and members of our management team or our strategic and operating partners is not a guarantee either: (1) that we have successfully identified a suitable candidate for our initial business combination; or (2) of any results with respect to the business combination. You should not rely on the historical record and performance of MKA and members of our management team or our strategic and operating partners as indicative of the future performance of an investment in us or the returns we will, or are likely to, generate going forward.

The Sponsor Agreement may be amended without shareholder approval.

The Sponsor Agreement contains provisions related to the waiver of redemption rights, the Sponsor and Insiders’ agreement to vote their shares in favor of the Transactions and other SPAC Stockholder Matters, to vote in favor of the appointment or election of individuals nominated for election of the Post-Closing Company Board and to pay certain transaction expenses or to forfeit certain of the CCIX Founder Shares held by such Sponsor or Insider. The CCIX Board, in exercising its business judgment and subject to its fiduciary duties, may choose to approve one or more amendments to the Sponsor Agreement. Any such amendments to the agreement would not require approval from CCIX shareholders and may have an adverse effect on the value of an investment in our securities.

Even if we consummate the business combination, there is no guarantee that the CCIX Warrants will ever be in the money, and they may expire worthless.

Upon the Closing, the CCIX Warrants will become Post-Closing Company public warrants. The exercise price for the Post-Closing Company warrants will be $11.50 per share of Post-Closing Company common stock, subject to adjustment. There is no guarantee that the CCIX Warrants, following the consummation of the business combination, will ever be in the money prior to their expiration, and as such, the CCIX Warrants may expire worthless.

<div align='center'>126</div>

We may amend the terms of the CCIX public warrants in a manner that may be adverse to holders of CCIX public warrants with the approval by the holders of at least 50% of the then-outstanding CCIX public